| Actions en circulation | 191,698,695 shares |
| Actions d'initiés | 478 504 883 shares |
| Nombre total d'initiés | 42 |
Indice de confiance des initiés
L'indice de confiance des initiés identifie les entreprises achetées par les initiés.
Il est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés de capitalisation d'initiés. Le modèle de notation utilise une combinaison du nombre net d'initiés ayant acheté des actions au cours des 90 derniers jours, du nombre total d'actions achetées en pourcentage du flottant et du nombre total d'actions détenues par les initiés. Le nombre varie de 0 à 100, les chiffres les plus élevés indiquant un niveau d'accumulation supérieur à celui de ses pairs, et 50 étant la moyenne.
Fréquence de mise à jour : Quotidienne
Indice de confiance des dirigeants
L'indice de confiance des dirigeants identifie les entreprises dont les actions sont achetées par des dirigeants d'entreprise.
Par définition, les dirigeants d'entreprise sont des initiés, mais contrairement à d'autres initiés (actionnaires à 10 % et membres du conseil d'administration), les dirigeants travaillent quotidiennement pour l'entreprise et utilisent leur propre argent lorsqu'ils effectuent des opérations (les actionnaires à 10 % et les membres du conseil d'administration sont souvent des gestionnaires de fonds qui gèrent l'argent d'autrui). À ce titre, les opérations d'initiés réalisées par les dirigeants sont beaucoup plus significatives et doivent être traitées de manière appropriée.
Comme l'indice de confiance des initiés, l'indice de confiance des dirigeants est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés d'accumulation de dirigeants.
Fréquence de mise à jour : Quotidienne
Principaux indicateurs des initiés
Cette carte montre comment l'entreprise se positionne par rapport à divers indicateurs d'initiés. La position en centile montre comment cette entreprise se situe par rapport aux autres entreprises sur les marchés américains. Une position plus élevée indique une meilleure situation.
Par exemple, il est généralement admis que les achats d'initiés sont un indicateur positif, de sorte que les entreprises dont les achats d'initiés sont plus nombreux se positionnent mieux que celles dont les achats d'initiés sont moins nombreux (ou même les ventes d'initiés).
Pourcentage du flottant acheté par les initiés (position)
0.000 %( )
5498 out of 11224Le pourcentage du flottant acheté par les initiés est le nombre total d'actions achetées par les initiés moins le nombre total d'actions vendues par les initiés au cours des 90 derniers jours, divisé par le flottant total et multiplié par 100.
Graphique des opérations d'initiés
Les opérations d'initiés de Arbutus Biopharma Corporation sont présentées dans le graphique suivant. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. En général, il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations matérielles non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leurs propres entreprises. Toutefois, ils doivent déclarer toutes les transactions à la SEC au moyen d'un formulaire 4.
Liste d'initiés et indicateurs de rentabilité
Ce tableau présente la liste des initiés connus et est généré automatiquement à partir des dépôts communiqués à la SEC. Outre les noms, le titre le plus récent et la désignation du directeur, du dirigeant ou du propriétaire à 10 %, nous indiquons les dernières participations divulguées. En outre, lorsque cela est possible, nous indiquons les performances historiques des opérations d'initiés. La performance historique des transactions est une moyenne pondérée de la performance des opérations d'achat réelles sur le marché public effectuées par l'initié. Pour plus d'informations sur le mode de calcul, regardez ce webinaire sur YouTube.
See our leaderboard of most profitable insider traders.
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
| Abrams Michael J. Managing Director - [O] | 42 097 | 42 097 | |
| Daniel D Burgess | 41 000 | ||
| Brennan Paul A. Sr VP, Business Develop - [O] | 38 000 | 38 000 | |
| Herbert J Conrad Director - [D] | 0 | 0 | |
| Andrew Cheng | 22 000 | ||
| Collier William H. President and CEO, Director - [D] [O] | 216 500 | 216 500 | |
| Bruce Cousins | 200 000 | ||
|
Dexxon Holdings Ltd.
10% Owner -
|
32 027 080 | 32 027 080 | |
|
Matthew Gline
Director, 10% Owner -
[D]
|
77 694 924 | 77 694 924 | |
| David C Hastings Chief Financial Officer - [O] | 249 824 | 249 824 | |
| Richard C Jr Henriques Director - [D] | 1 000 | 1 000 | |
| Higgins Patrick T. President & COO - [O] | 3 529 630 | 3 529 630 | |
| Elizabeth Howard EVP, GC, Compliance - [O] | 86 024 | 86 024 | |
| Donald Gordon Jewell Director - [D] | 969 330 | 969 330 |
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
| Frank Karbe Director - [D] | 10 000 | 10 000 | |
| Daniel L Kisner Director - [D] | 25 000 | 25 000 | |
| Mark Kowalski | 85 000 | ||
|
Andrew Lo
10% Owner -
|
32 027 080 | 32 027 080 | |
| Peter Lutwyche Chief Tech. Operations Officer - [O] | 77 516 | 77 516 | |
| Keith S Manchester Director - [D] | 46 069 | 46 069 | |
|
Patrick Machado
10% Owner -
|
32 027 080 | 32 027 080 | |
| McElhaugh Michael J. Interim President & CEO, Director - [D] [O] | 1 658 003 | 1 658 003 | |
| James R Meyers | 41 000 | ||
| Murray Mark J. Director - [D] | 341 396 | 341 396 | |
| Naftzger J. Christopher General Counsel and CCO - [O] | 140 544 | 140 544 | |
| Myrtle S Potter | 22 000 | ||
| Peggy V Phillips Director - [D] | 20 000 | 20 000 | |
| Gaston Picchio | 256 500 |
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
|
QVT Associates GP LLC
Director, 10% Owner -
[D]
|
32 027 080 | 32 027 080 | |
|
Vivek Ramaswamy
Director, 10% Owner -
[D]
|
32 081 995 | 32 081 995 | |
|
Roivant Sciences Ltd.
10% Owner -
|
38 847 462 | 38 847 462 | |
|
SVF Investments (UK) Ltd
10% Owner -
|
32 027 080 | 32 027 080 | |
| Karen Sims Chief Medical Officer - [O] | 155 494 | 155 494 | |
| Sofia Michael J. Chief Scientific Officer - [O] | 1 485 121 | 1 485 121 | |
|
Sundheim Daniel S.
10% Owner -
|
32 027 080 | 32 027 080 | |
| Symonds William T. Chief Development Officer, Director - [D] [O] | 512 654 | 512 654 | |
| Frank Torti | 41 000 | ||
| Tram Tran | 41 000 | ||
|
Viking Global Investors Lp
10% Owner -
|
32 027 080 | 32 027 080 | |
|
Viking Global Performance Llc
10% Owner -
|
32 027 080 | 32 027 080 | |
| Koert VandenEnden Interim CFO - [O] | 5 500 | 5 500 | |
| Eric Venker | 0 |
Report errors via our new Insider Auditing Tool
Historique des achats d'initiés - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans ABUS / Arbutus Biopharma Corporation. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque transaction et les résultats sont théoriques .
Le tableau suivant présente les achats sur le marché public les plus récents qui ne faisaient pas partie d'un plan de trading automatique.
| Date de la transaction | Initiés | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Base de coût | Jours jusqu'au Max |
Prix au Max |
Bénéfice Max ($) |
Rendement maximal (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | HENRIQUES RICHARD C JR | 1 000 | 6,9500 | 1 000 | 6,9500 | 6 950 | 24 | 7.56 | 610 | 8,78 |
Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.
Historique des ventes d'initiés - Analyse des pertes à court terme
Dans cette section, nous analysons l'évitement des pertes à court terme de chaque vente d'initié non planifiée et réalisée sur le marché public dans ABUS / Arbutus Biopharma Corporation. Un schéma cohérent d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur l'année qui suit chaque transaction, et les résultats sont théoriques .
Le tableau suivant présente les ventes les plus récentes sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.
Historique des transactions
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| Date de dépôt |
Date de transaction |
Formulaire | Initié | Libellé | Nom du titre | Code | Direct | Prix d'exercice |
Prix unitaire |
Unités Modifié |
Valeur Modifiée (1K) |
Options restantes |
Actions restantes |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 3 | Gline Matthew By Roivant Sciences Ltd. | ABUS | Common Shares | I | 38 847 462 | ||||||||
| 2025-02-19 | 2025-02-14 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 90 100 | 249 824 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 177 000 | 1 658 003 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 54 300 | 140 544 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Sims Karen | ABUS | Common Shares | D | 49 300 | 155 494 | ||||||
| 2025-02-05 | 2025-02-04 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 3,2830 | -11 333 | -37 | 86 244 | ||||
| 2025-02-05 | 2025-02-04 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 3,2830 | -23 790 | -78 | 1 481 003 | ||||
| 2025-02-05 | 2025-02-04 | 4 | Sims Karen | ABUS | Common Shares | D | 3,2830 | -19 348 | -64 | 106 194 | ||||
| 2025-02-05 | 2025-02-04 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 3,2830 | -22 183 | -73 | 159 724 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 3,6895 | -8 846 | -33 | 46 069 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 0,5600 | 54 915 | 31 | 54 915 | ||||
| 2024-02-05 | 2024-02-02 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 2,3125 | -9 593 | -22 | 181 907 | ||||
| 2024-02-05 | 2024-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 112 500 | 191 500 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sims Karen | ABUS | Common Shares | D | 2,3125 | -4 358 | -10 | 125 542 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sims Karen | ABUS | Common Shares | D | 101 000 | 129 900 | ||||||
| 2024-02-05 | 2024-02-01 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 95 100 | 95 100 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,3125 | -10 164 | -24 | 1 504 793 | ||||
| 2024-02-05 | 2024-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 123 800 | 1 514 957 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 2,3125 | -9 982 | -23 | 1 485 121 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 109 500 | 1 495 103 | ||||||
| 2023-07-12 | 3 | Sims Karen | ABUS | Common Shares | D | 28 900 | ||||||||
| 2023-02-03 | 2023-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 82 200 | 1 385 603 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 83 700 | 1 391 157 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Collier William H. | ABUS | Common Shares | D | 216 500 | 216 500 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 79 000 | 79 000 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Howard Elizabeth | ABUS | Common Shares | D | 69 700 | 86 024 | ||||||
| 2022-05-26 | 2022-05-25 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Meyers James R | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | BURGESS DANIEL D | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Torti Frank | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-01-20 | 2022-01-20 | 4 | Picchio Gaston | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 256 500 | 721 | 256 500 | |||
| 2022-01-20 | 2022-01-20 | 4 | Sofia Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285 000 | 801 | 285 000 | |||
| 2022-01-20 | 2022-01-20 | 4 | Howard Elizabeth | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 237 500 | 667 | 237 500 | |||
| 2022-01-20 | 2022-01-20 | 4 | HASTINGS DAVID C | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285 000 | 801 | 285 000 | |||
| 2022-01-20 | 2022-01-20 | 4 | McElhaugh Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 325 850 | 916 | 325 850 | |||
| 2022-01-20 | 2022-01-20 | 4 | Collier William H. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 787 550 | 2 213 | 787 550 | |||
| 2021-12-03 | 2021-12-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 5,0900 | -200 000 | -1 018 | 1 303 403 | ||||
| 2021-11-12 | 2021-11-09 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 3,50 | 44 000 | 44 000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Series A participating convertible preferred shares | D | 7,13 | -1 164 000 | 0 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Common shares, without par value | D | 22 833 922 | 38 847 462 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Meyers James R | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Torti Frank | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Picchio Gaston | ABUS | Stock Options | D | 4,33 | 250 000 | 250 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 4,33 | 250 000 | 250 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Collier William H. | ABUS | Stock Options | D | 4,33 | 675 000 | 675 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 4,33 | 200 000 | 200 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 4,33 | 249 000 | 249 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 4,33 | 290 000 | 290 000 | |||||
| 2021-02-10 | 2021-02-09 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -20 000 | -100 | 1 307 457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0032 | -10 000 | -50 | 1 327 457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -30 000 | -150 | 1 337 457 | ||||
| 2020-09-25 | 2020-09-23 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 70 000 | 70 000 | |||||
| 2020-09-25 | 2020-09-23 | 4 | Picchio Gaston | ABUS | Common Stock | D | 3,35 | 50 000 | 50 000 | |||||
| 2020-07-27 | 2020-07-23 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0100 | -20 000 | -100 | 1 367 457 | ||||
| 2020-06-01 | 2020-05-28 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 262 313 | 262 313 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Meyers James R | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Torti Frank | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 3,35 | 200 000 | 200 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 3,35 | 100 000 | 100 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 367 087 | 367 087 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Picchio Gaston | ABUS | Stock Options | D | 3,35 | 150 000 | 150 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 3,35 | 250 000 | 250 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 3,35 | 79 500 | 79 500 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Torti Frank | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Meyers James R | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | POTTER MYRTLE S | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Cheng Andrew | ABUS | Stock Options | D | 1,50 | 60 000 | 60 000 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Collier William H. | ABUS | Employee Stock Option (Right to Buy) | D | 2,18 | 1 112 000 | 1 112 000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 357 500 | 357 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | McElhaugh Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 104 500 | 104 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 145 000 | 145 000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Picchio Gaston | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-13 | 2018-12-11 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 4,44 | 7 500 | 7 500 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 1,35 | -25 000 | 0 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Common Shares | D | 1,3500 | 25 000 | 34 | 341 396 | ||||
| 2018-11-27 | 2018-11-26 | 4 | Torti Frank | ABUS | Director Share Option (right to buy) | D | 4,72 | 44 000 | 44 000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | POTTER MYRTLE S | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44 000 | 44 000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | Meyers James R | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44 000 | 44 000 | |||||
| 2018-10-10 | 2018-10-08 | 4 | Picchio Gaston | ABUS | Employee Share Option (Right to Buy) | D | 9,38 | 200 000 | 200 000 | |||||
| 2018-08-15 | 2018-08-13 | 4/A | Sofia Michael J. Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 | ABUS | Common Shares | I | 9,5143 | -4 250 | -40 | 167 162 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 9,5143 | -4 250 | -40 | 1 499 153 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 10,0000 | -10 000 | -100 | 1 503 403 | ||||
| 2018-07-10 | 2018-07-09 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,9060 | -10 000 | -89 | 1 513 403 | ||||
| 2018-07-10 | 2018-07-06 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4500 | -10 000 | -84 | 1 523 403 | ||||
| 2018-07-06 | 2018-07-05 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4000 | -10 000 | -84 | 1 533 403 | ||||
| 2018-07-06 | 2018-07-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10 000 | -80 | 1 543 403 | ||||
| 2018-06-25 | 2018-06-19 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | MANCHESTER KEITH S | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | Ramaswamy Vivek | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-21 | 2018-06-19 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 6,75 | 200 000 | 200 000 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 160 000 | 160 000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 25 000 | 25 000 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | -27 007 | 0 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Common Shares | D | 0,3540 | 27 007 | 10 | 316 396 | ||||
| 2018-04-17 | 2018-04-16 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 418 187 | 418 187 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 150 000 | 150 000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 30 000 | 30 000 | |||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5 500 | ||||||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5 500 | ||||||||
| 2018-01-16 | 2018-01-12 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Lo Andrew | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Machado Patrick See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2017-10-18 | 2017-10-16 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Lo Andrew See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Machado Patrick | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-05 | 2017-10-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10 000 | -80 | 1 553 403 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,6750 | -20 000 | -74 | 171 412 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,7500 | -10 000 | -38 | 191 412 | ||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-06-23 | 2017-06-21 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | Ramaswamy Vivek | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125 000 | 125 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 450 000 | 450 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 150 000 | 150 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 50 000 | 50 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 200 000 | 200 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125 000 | 125 000 | |||||
| 2017-03-27 | 2017-03-24 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 3,15 | 50 000 | 50 000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 13 503 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 675 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Common Shares | D | 0,3455 | 14 178 | 5 | 42 097 | ||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Warrants | D | 2,57 | -5 000 | 0 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Common Shares | D | 2,5688 | 5 000 | 13 | 289 389 | ||||
| 2016-06-07 | 2016-06-03 | 4 | KARBE FRANK | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 50 000 | 50 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 145 000 | 145 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Kowalski Mark | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 85 000 | 85 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 60 000 | 60 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 450 000 | 450 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Symonds William T. | ABUS | Executive Stock Option (Right to Buy) | D | 3,94 | 25 000 | 25 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 100 000 | 100 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 120 000 | 120 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35 000 | 35 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75 000 | 75 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100 000 | 100 000 | |||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77 516 | ||||||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77 516 | ||||||||
| 2015-12-22 | 2015-07-09 | 4 | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100 000 | 100 000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75 000 | 75 000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35 000 | 35 000 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -219 428 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Common Shares | D | 0,4444 | 219 428 | 98 | 284 389 | ||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -17 044 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Common Shares | D | 0,4444 | 17 044 | 8 | 27 919 | ||||
| 2015-08-26 | 2015-08-24 | 4 | HENRIQUES RICHARD C JR | ABUS | Common Shares | D | 6,9500 | 1 000 | 7 | 1 000 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | CONRAD HERBERT J | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-04-08 | 2015-03-30 | 4 | HENRIQUES RICHARD C JR | TKMR | Stock Option (right to buy) | D | 17,57 | 15 000 | 15 000 | |||||
| 2015-04-07 | 2015-03-30 | 4 | CONRAD HERBERT J | TKMR | Stock Option (right to buy) | D | 17,57 | 15 000 | 15 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Abrams Michael J. | TKMR | Stock Option (right to buy) | D | 17,57 | 50 000 | 50 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Cousins Bruce | TKMR | Stock Option (right to buy) | D | 17,57 | 80 000 | 80 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Murray Mark J. | TKMR | Stock Option (right to buy) | D | 17,57 | 180 000 | 180 000 | |||||
| 2015-03-16 | 3 | CONRAD HERBERT J | TKMR | Common Stock | D | 0 | ||||||||
| 2015-03-16 | 3 | MANCHESTER KEITH S | TKMR | Common Stock, no par value | I | 0 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3 328 218 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1 966 227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1 966 227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3 328 218 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512 654 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512 654 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3 529 630 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3 529 630 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32 081 995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16 123 370 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32 081 995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16 123 370 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38 000 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38 000 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21 750 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21 750 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129 922 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129 922 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969 330 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969 330 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77 516 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77 516 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20 000 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20 000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10 000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10 000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25 000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25 000 |
P
Achat sur le marché public ou privé d'un titre non dérivé ou dérivé
S
Vente sur le marché public ou privé d'un titre non dérivé ou dérivé
A
Attribution, récompense ou autre acquisition de titres de l'entreprise (comme une option).
C
Conversion d'un produit dérivé
D
Vente ou transfert de titres à l'entreprise
F
Paiement du prix d'exercice ou de la dette fiscale en utilisant une partie des titres reçus de l'entreprise
G
Don de titres par ou à l'initié
K
Swaps d'actions et opérations de couverture similaires
M
Exercice ou conversion d'un titre dérivé reçu de l'entreprise (tel qu'une option)
V
Une transaction déclarée volontairement sur le formulaire 4
J
Autre (accompagnée d'une note de bas de page décrivant la transaction)
